Envoy Capital Group Inc. 

(Public, NASDAQ:ECGI)   Watch this stock   
Find more results for ECGI

Key stats and ratios

Q2 (Jun '09) 2008
Net profit margin -61.80% -90.20%
Operating margin -61.80% -57.44%
EBITD margin - -50.60%
Return on average assets -21.78% -23.28%
Return on average equity -25.11% -21.91%
Employees 87 -

Address

172 John Street
Toronto, ON M5T 1X5
Canada
+1-416-5931212 (Phone)
+1-416-5934434 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money
Options - Morningstar
Research Reports - Yahoo Finance

Envoy Capital Group Inc. discussed on blogs

Movie Quote Site » Courteney Cox's Family Issue Suspends Cougar ... - Movie Quote Site - Movie Quote Site - 15 hours ago
First Principles Calculations of Linear and Second-Order Optical ... - Li-Chuan Tang, Yia-Chung Chang, Jung-Yau Huang, Ming-Hsien Lee, Chen-Shiung Chang - Recent articles in Jpn. J. Appl. Phys. - Nov 20, 2009

Envoy Capital Group Inc. discussions

  View all discussions »

Description

Envoy Capital Group Inc. (Envoy) is an international consumer and retail branding company, and a merchant banking and financial services company. The Company is engaged in providing marketing, communications, and consumer and retail branding services for promoting clients’ products, services and business messages utilizing such media as print, broadcast and the Internet. Envoy provides consulting, branding, packaging and retail design services to clients in Canada, the United States, Mexico, United Arab Emirates, China and South America, as well as project work for clients in other countries worldwide. Envoy conducts its branding services through its wholly owned subsidiary, Watt International Inc. (Watt International), which is a brand strategy and design consultancy. Watt International provides services, such as strategic brand consulting, corporate identity and communications, retail branding and store design, and package design.

Officers and directors

David Hull
Chairman of the Board, Independent Director
Age: 52
Bio & Compensation - Reuters
J. Joseph Leeder
President, Chief Executive Officer
Age: 54
Bio & Compensation - Reuters
Andrew Patient
Chief Financial Officer
Bio & Compensation - Reuters
Darlene Soper
Corporate Secretary
Bio & Compensation - Reuters
Geoffrey B. Genovese
Director
Age: 54
Bio & Compensation - Reuters
John H. Bailey
Director
Age: 63
Bio & Compensation - Reuters
David B. Parkes
Director
Bio & Compensation - Reuters
Linda Gilbert
Independent Director
Bio & Compensation - Reuters